In vivo studies have shown that PTHrP plays a causative role in cancer progression, including breast cancer [18], giant cell tumor of bone [19], prostate cancer [20], pancreatic cancer [21], and kidney cancer [22,29]. Here, PTHLH is linked to kidney cancer.